MX2014013083A - Composicion farmaceutica inyectable de dexketoprofeno y tramadol. - Google Patents

Composicion farmaceutica inyectable de dexketoprofeno y tramadol.

Info

Publication number
MX2014013083A
MX2014013083A MX2014013083A MX2014013083A MX2014013083A MX 2014013083 A MX2014013083 A MX 2014013083A MX 2014013083 A MX2014013083 A MX 2014013083A MX 2014013083 A MX2014013083 A MX 2014013083A MX 2014013083 A MX2014013083 A MX 2014013083A
Authority
MX
Mexico
Prior art keywords
dexketoprofen
tramadol
pharmaceutical composition
injectable pharmaceutical
composition
Prior art date
Application number
MX2014013083A
Other languages
English (en)
Other versions
MX359106B (es
Inventor
José Miguel Rizo Martínez
Antonia Gómez Calvo
Nuria Sanz Menéndez
Ángel Muñoz Ruíz
Fernando Martinez Alzamora
Original Assignee
Farmalider Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider Sa filed Critical Farmalider Sa
Publication of MX2014013083A publication Critical patent/MX2014013083A/es
Publication of MX359106B publication Critical patent/MX359106B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

La presente invención se refiere a una composición farmacéutica inyectable de dexketoprofeno y tramadol como principios activos. En particular, se trata de una solución de dexketoprofeno y tramadol en una mezcla de agua para inyección y al menos un cosolvente. La presente invención también se refiere a un procedimiento para la preparación de dicha composición, a una forma farmacéutica de dosificación unitaria que la contiene y a su uso para el tratamiento del dolor de intensidad moderado a severo, inflamación y/o fiebre.
MX2014013083A 2012-04-30 2013-04-29 Composicion farmaceutica inyectable de dexketoprofeno y tramadol. MX359106B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201200450A ES2432222B1 (es) 2012-04-30 2012-04-30 Composición farmacéutica inyectable de dexketoprofeno y tramadol
PCT/ES2013/000106 WO2013164498A1 (es) 2012-04-30 2013-04-29 Composición farmacéutica inyectable de dexketoprofeno y tramadol

Publications (2)

Publication Number Publication Date
MX2014013083A true MX2014013083A (es) 2015-04-14
MX359106B MX359106B (es) 2018-09-14

Family

ID=49514233

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013083A MX359106B (es) 2012-04-30 2013-04-29 Composicion farmaceutica inyectable de dexketoprofeno y tramadol.

Country Status (7)

Country Link
EP (1) EP2857016B1 (es)
BR (1) BR112014027002A2 (es)
CO (1) CO7170180A2 (es)
ES (1) ES2432222B1 (es)
MX (1) MX359106B (es)
RU (1) RU2660356C2 (es)
WO (1) WO2013164498A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3928766A1 (en) * 2020-06-26 2021-12-29 Usso Barnas Pharmaceutical composition and use thereof
EP4188337A1 (en) * 2020-07-31 2023-06-07 KRKA, d.d., Novo mesto Formulation containing dexketoprofen and tramadol and method for making the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1546478A (fr) 1967-01-27 1968-11-22 Rhone Poulenc Sa Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
AU661723B2 (en) * 1991-10-30 1995-08-03 Mcneilab, Inc. Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
CN1204891C (zh) * 2001-12-27 2005-06-08 沈阳药科大学 一种含有曲马多的注射液及其应用
US7090859B2 (en) * 2002-12-13 2006-08-15 Ronald Thomas Haas Ketoprofen compositions and methods of making them
US20110098284A1 (en) * 2005-04-28 2011-04-28 Najib Babul Methods and compositions for treating pain
BRPI0700133A (pt) 2007-01-29 2008-09-16 Incrementha P D & I Pesquisa D composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
WO2008150324A1 (en) * 2007-03-26 2008-12-11 Theraquest Biosciences, Inc. Subanalgesic doses of drug combinations

Also Published As

Publication number Publication date
BR112014027002A2 (pt) 2017-06-27
RU2660356C2 (ru) 2018-07-05
EP2857016B1 (en) 2017-02-22
RU2014148062A (ru) 2016-06-27
ES2432222B1 (es) 2014-06-10
EP2857016A4 (en) 2015-12-23
WO2013164498A1 (es) 2013-11-07
EP2857016A1 (en) 2015-04-08
ES2432222A1 (es) 2013-12-02
MX359106B (es) 2018-09-14
CO7170180A2 (es) 2015-01-28

Similar Documents

Publication Publication Date Title
AR090491A1 (es) Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fumarato de dimetilo
UA109991C2 (xx) Карбаматні сполуки, їх отримання і застосування
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
MX2013003635A (es) Compuestos de n-heteroarilo.
UA113962C2 (xx) Фармацевтична композиція, яка містить апоморфін як активний інгредієнт
WO2013090523A3 (en) Methods, systems, and compositions for cell-derived/vesicle-based microrna delivery
MX2019008817A (es) Formulacion de liberacion prolongada para reducir la frecuencia de miccion y metodo de uso de la misma.
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
EA201790223A1 (ru) Водный препарат, содержащий парацетамол и ибупрофен
IN2014MN02269A (es)
EA201490045A1 (ru) Дейтерированные 1-пиперазино-3-фенилинданы, применяемые для лечения шизофрении
MX2015010486A (es) Composicion masticable para administracion oral y proceso para preparar la misma.
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.
MX2014013083A (es) Composicion farmaceutica inyectable de dexketoprofeno y tramadol.
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
ES2422563A1 (es) Composición farmacéutica inyectable de ibuprofeno y arginina, su procedimiento de preparación, forma de dosificación unitaria y utilización de la misma
NZ629475A (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
MX354614B (es) Composición farmacéutica de diosmina y hesperidina y su uso en dolor neuropático.
UA111785C2 (uk) Композиція для лікування бородавок та спосіб лікування бородавок
IN2013MU02111A (es)
IN2013MU01155A (es)
IN2013MU01154A (es)
IN2013MU01157A (es)
IN2013MU01156A (es)
IN2013MU01243A (es)

Legal Events

Date Code Title Description
FG Grant or registration